Skip to content

MethodX

Active Private limited companyfounded 2022active for 4 yearsAvenue du Zodiaque 88, 1410 WaterlooKBO/BCE: BE 0781.563.246

Overview

Lifetime

4 annual accounts with figures on one time axis
peak €255,617 (2025)
€255,617▲ 25.0%
peak €168,026 (2025)
€168,026▲ 41.9%
peak €294,164 (2024)
€294,164unchanged
€185,267▲ 18×
Board2 names since 2022
2 directorsMUNIER Stéphane Michel Bruno and 1 other
Documentsfilings and deeds
02-04-2026120 days before the deadline
2025micro format
Gross margin from €204,422 to €255,617Result from €118,403 to €168,026Appointment: Munier Antoine (director) 27-10Dividend €168,026Debts from €10,176 to €185,267Cash from €101,368 to €255,086

Key points

from the 2025 annual accounts

Equity

€294,164 =
294,1642024+168,026Profit-168,026Dividend294,1642025

MethodX paid out €168,026 in dividends. That is 100% of the 2025 profit.

Turnover

≈ €510,000 estimated

The micro format states no turnover.

Debts

€185,267 ▲ 18×
Taxes and wages
+29,414
Suppliers
+352
The rest
+145,324

Debts rose by €175,091 in 2025.

Liquidity

2.54 was 28.26 in 2024

Short-term debts rose from €10,176 to €185,267.

Filings

4 annual accounts 2 late
AprilJune31 JulyOctober2022202320242025

The 2022 accounts came latest: 25 days after the end of the period.

Position in the sector

€168,026

Higher net result than 90% of companies in research and development. Sector median €27,659 · 620 companies.

Checked score

96
Excellent
Financially stronger than 65% of micro companies in research and development (NACE 72)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.1% across 932 companies (NACE 72, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

83-17equity 57.8% of total assets
84-4short-term debt 36.4% · cash 50.1%
100+1return on assets 33.0%

Score breakdown

lowers risk
Liquidity: current ratio 2.54, cash €255,086
Sector: Scientific research and development (NACE 72)
Size: total assets €509,257
Equity €294,164 (57.8% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 50% of them on solvency, 72% on liquidity, 90% on profitability and 46% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 3,127 companies had the same profile as MethodX has now. Each dot stands for 8 companies, two years later.

97.2%
were still trading
1.9%
stopped another way
0.8%
went bankrupt
  • Small
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of MethodX itself: < 0.1% within 12 months.

Test of the method

The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,127 companies, not a prediction for MethodX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €25,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 2.54 (28.26 in 2024), above the usual 1.5. Short-term debt is 36.4% and cash 50.1% of total assets. 42.2% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

5 signals, none raises the risk
Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 2.54, cash €255,086
NBB · annual accounts
lowers risk · Sector: Scientific research and development (NACE 72)
KBO
lowers risk · Size: total assets €509,257
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €294,164 (57.8% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-04-2026, 120 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
120 days early
2024
29 days early
2023
2 days late
2022
25 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 31 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 July (3 of the last 4 accounts filed within 38 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Board and ownership

Board & ownership

Recent changes

Reappointment: Munier Antoine (director) General meeting of 31-08-2026 · Gazette deed
Appointment: Munier Antoine (director) General meeting of 06-10-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0781563246
Incorporation Founding capital of €10,000, 1,000 shares · Appointment: MUNIER Stéphane Michel Bruno (director) · Registered office clause: avenue du Zodiaque 88, 1410 Waterloo · published on 07-02-2022 · Gazette deed
All 14 events

Comparable companies

same main activity, similar in size and age
Company
MethodX Waterloo €509,257 €255,617 57.8% -
SETIS SYSTEMS Lochristi €385,933 €230,419 75.2% 2.7
TAKHIM FOR TECHNOLOGY AND BUSINESS SERVICES Wavre €647,200 €380,396 40.3% -
BGTech project Jodoigne €605,171 €214,708 48.5% -
Heart Rhythm Research Center Sint-Genesius-Rode €483,417 €138,973 62.5% -
Dr. S. Beeckman - Dr. B. Van de Maele Oostkamp €321,519 €341,196 76.6% -
CIVASEL Ciney €530,784 €275,420 72.8% 2

These companies have the same main activity as MethodX: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €322,000 and €647,000, founded between 2020 and 2023.

Official details

Source: KBO
Status
Active since 03-02-2022Normal situation
Activity
Other research and development on natural sciencesNACE 72109and 1 other
Establishment unit
2.327.665.2501410 Waterloo, since 03-02-2022
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

€255,617▲ 25.0%
€168,026▲ 41.9%
€294,164=
€509,257▲ 52.8%
Filing
Filed on 02-04-2026, 120 days before the end of the filing period
Financials

Insights on MethodX

MethodX files the micro format. That format states no turnover. The gross margin rose from €64,918 in 2022 to €255,617 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 02-04-2026, 120 days before the deadline
€255,617
▲ 25.0%
€243,628
▲ 21.8%
€168,026
▲ 41.9%
€285,589
▲ 2.9%
57.8%
▼ 30.5 percentage points
2.54
▼ 25.72

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €510,000. Estimated: probably between €360,000 and €750,000.

Balance sheet

balance sheet total €509,257 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

57.8%

Higher than 47% of 620 companies in 2025.

2.54

Higher than 48% of 580 companies in 2025.

33.0%

Higher than 82% of 597 companies in 2025.

MethodX Middle half of the sector 80% of the sector Micro accounts in research and development (NACE 72)

Net result: top quarter · Equity: middle half · Balance sheet total: middle half · Working capital: top quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022
Balance sheet: assets
20/58 509,257333,187223,55079,092
21/28 38,40245,561--
22/27 38,40245,561--
24 38,40245,561--
29/58 470,856287,626223,55079,092
40/41 109,10580,38343,3128,246
40 36,24636,07235,019-
41 72,85944,3118,2938,246
50/53 99,914100,00050,000-
54/58 255,086101,368130,23770,846
490/1 6,7505,874--
Balance sheet: equity and liabilities
10/49 509,257333,187223,55079,092
10/15 294,164294,164175,76156,607
10/11 10,00010,00010,00010,000
13 284,164284,164165,76146,607
133 284,164284,164165,76146,607
16 29,82628,84629,415-
160/5 29,82628,84629,415-
164/5 29,82628,84629,415-
17/49 185,26710,17618,37322,485
42/48 185,26710,17618,08922,485
43 2,503---
430/8 2,503---
44 35204,795-
440/4 35204,795-
45 39,59010,1769,55222,485
450/3 39,59010,1769,55222,485
47/48 142,822-3,743-
492/3 --284-
Income statement
9900 255,617204,422212,53664,918
630 10,8134,870--
635/8 980-56929,415-
640/8 197138--
9901 243,628199,983183,12164,918
75/76B 8,1093,185--
75 8,1093,185--
65/66B 31,63634,8223,860175
65 31,63634,8223,860113
66B ---62
9903 220,100168,346179,26164,743
67/77 52,07449,94360,10718,136
9904 168,026118,403119,15446,607
9905 168,026118,403119,15446,607
Appropriation of the result
9906 168,026118,403119,15446,607
691/2 -118,403119,15446,607
6921 -118,403119,15446,607
694/7 168,026---
694 168,026---
Document PDFPDFPDFPDF

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 02-04-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 02-04-2026 2026-00075099 PDF
31-12-2024 micro format 02-07-2025 2025-00251567 PDF
31-12-2023 micro format 02-08-2024 2024-00328994 PDF
31-12-2022 micro format 25-08-2023 2023-00363169 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022
254,441204,853--
178,839123,273--
3,65350,431--
153,718-28,86959,391-
285,589277,449205,46056,607
57.8%88.3%78.6%71.6%
2.5428.2612.363.52
0.630.030.100.40
57.1%40.3%67.8%82.3%
33.0%35.5%53.3%58.9%
8.045.88--

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item2025202420232022
Tangible fixed assets€3,653€50,431--
€10,813€4,870--

Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)

Insights on MethodX

The operating result for 2025 is 22% higher than in 2024 and the highest since 2022. It is the third rise in a row.

Debt's share of the balance-sheet total rises from 3.1% to 36.4%. Debt is higher.

Board & ownership

Board

2 directors, no change since August 2026
Director (not named in the articles)
appointed by deed of 07-02-2022 term without a fixed end
Director
appointed by deed of 27-10-2025

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
MUNIER Stéphane Michel Bruno
Director (not named in the articles)
Munier Antoine
Director (not named in the articles)
Board
Mandates as a list
  • MUNIER Stéphane Michel Bruno
    • Director (not named in the articles), appointed by deed of 07-02-2022, still in office
  • Munier Antoine
    • Director (not named in the articles), appointed by deed of 27-10-2025, still in office

See the board, name and registered office on a given date →

Control

Capital

Contribution
€10,000
Shares
1,000
Contribution per share
€10
Equity per share
€294 in 2025
Source
deed of 07-02-2022

Articles of association

DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 07-02-2022 (in French)
Board ruleThese rules set how the board is made up, meets and takes decisions.
“Fixe ou proportionnelle, rémunération du mandat d'administrateur”
deed of 27-10-2025 (in French)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Thursday of May at 18:00
deed of 07-02-2022 (in French)
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor
deed of 07-02-2022 (in French)

Network & group

No group

MethodX has no parent and no holdings in its annual accounts. MethodX shares no director with another company.

The LEI register names no parent.

At the same address

Avenue du Zodiaque 88, 1410 Waterloo · 2 other companies
QubeS.
registered office since 03-02-2022 · founded in 2022
total assets €1.6m (2025)
0781.564.929
S4CT
registered office since 26-07-2012 · founded in 2012
total assets €332,863 (2025)
0847.223.635

Timeline

Timeline

14 events since 2022

Deadline for the 2026 accounts: 31-07-2027

2026
Reappointment: Munier Antoine (director)General meeting of 31-08-20262 points ▸

Open the deed in the Belgian Official Gazette

Annual accounts 2025 filed PDFmicro format · 120 days before the deadline
2025
Highest result from 2022 to 2025 net €168,026 ▲41.9% The operating result of €243,628 and the net result of €168,026 are both a record.
Appointment: Munier Antoine (director)General meeting of 06-10-20252 points ▸
  • General meeting, 06-10-2025
  • Director appointment, Munier Antoine (director (not named in the articles))

Open the deed in the Belgian Official Gazette

Annual accounts 2024 filed PDFmicro format · 29 days before the deadline
2024
Liquidity more than doubled current ratio 28.26 The current ratio rises from 12.36 to 28.26. Short-term debt falls from €18,089 to €10,176.
Equity above €200,000 equity €294,164 ▲67.4% With a profit in every financial year since 2022, equity grows to €294,164.
Annual accounts 2023 filed PDFmicro format · 2 days late
2023
Liquidity more than triples current ratio 12.36 The current ratio rises from 3.52 to 12.36. Short-term debt falls from €22,485 to €18,089.
Equity above €150,000 equity €175,761 ▲210% With a profit in every financial year since 2022, equity grows to €175,761.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0781563246
Annual accounts 2022 filed PDFmicro format · 25 days late
2022
IncorporationFounding capital of €10,000, 1,000 shares · Appointment: MUNIER Stéphane Michel Bruno (director) · Registered office clause: avenue du Zodiaque 88, 1410 Waterloo · published on 07-02-20223 points ▸
  • Founding capital, €10,000, 1,000 shares
  • Registered office clause, avenue du Zodiaque 88, 1410 Waterloo
  • Director appointment, MUNIER Stéphane Michel Bruno (director (not named in the articles))
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

First establishment Avenue du Zodiaque 88, Waterloo

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 3 February 2022, MethodX was incorporated as a private limited company, with a starting capital of €10,000.12 Today the board has 2 members.3 Total assets went from €79,092 in 2022 to €509,257 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 07-02-2022
  3. 3Belgian Official Gazette, 29-09-2026
  4. 4National Bank, annual accounts 2022 and 2025

Company details

Identity

Enterprise number
0781.563.246
VAT number
BE 0781.563.246
Peppol ID
0208:0781563246
Other Peppol ID
9925:BE0781563246
LEI code
98450064FBEJ5F967702 live in the LEI register
Legal form
Private limited company
Status
Active, normal situation
Founded
03-02-2022
Financial year
ends on 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Thursday of May at 18:00
deed of 07-02-2022 (in French)
Peppol
Reachable since 24-11-2023Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
MethodX in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 07-02-2022 (in French)

Activities

NACEBEL 2025
Codes under NACEBEL 2008
72190 Scientific research and development main activity
70220 Business consulting
PurposeThe purpose describes the activities the company may carry out under its articles.
“Toutes opérations se rapportant directement ou indirectement au management et à la consultance pour les entreprises,comprenant la gestion…”
10 activities
  1. Toutes opérations se rapportant directement ou indirectement au management et à la consultance pour les entreprises,comprenant la gestion notamment dans le domaine commercial et marketing,le domaine financier,le domaine opérationnel,le domaine technique,le domaine de la recherche et développement,le domaine de la gestion d’équipe,le domaine administratif et le domaine des ressources humaines
  2. Dans le cadre de recherche scientifique liée au développement de médicament,de dispositif médical ou de solution de santé digitale:toute application ou développement de méthodes statistiques et quantitatives:dans la conception et la conduite de cette recherche;dans l’analyse,l’interprétation,la présentation et la publication des données qui en découlent;dans le support d’une soumission réglementaire et d’accès au marché lié à cette recherche
  3. La prestation,directement ou indirectement,de tous services,consultance et formation informatique,statistique,et data science,liés à l’objet et la recherche clinique en général
  4. Toutes les activités se rapportant,directement ou indirectement,au domaine de l’informatique,des sites internet,des applications mobiles et internet et des bases de données,notamment,et sans que cette liste soit exhaustive,la consultance,la conception,la programmation,la réalisation,l’étude,la réalisation de projets,la promotion et la commercialisation de sites internet et de logiciels sur tous supports
  5. Pour tous les domaines d’activités ayant,directement ou indirectement,un lien avec son objet,l’achat,la vente,l’import,l’export,la conception,la fabrication,la réparation,l’entretien,l’assemblage et la commercialisation en gros et au détail de tout matériel,notamment et sans que cette liste soit exhaustive,le matériel informatique,le matériel de bureautique,le matériel de communication et le matériel promotionnel;l’achat et la vente de fournitures
  6. Pour tous les domaines d’activités ayant,directement ou indirectement,un lien avec son objet,la conception,l’organisation et la coordination de salons,de foires d’expositions et d’événement au sens le plus large
  7. Pour tous les domaines d’activités ayant,directement ou indirectement,un lien avec son objet,la conception,l’organisation,la coordination et la prestation de formations et séminaires au sens le plus large
  8. Toutes les activités se rapportant,directement ou indirectement,au domaine de l’audiovisuel,notamment,et sans que cette liste soit exhaustive,la direction artistique,la réalisation,la production,la promotion et la distribution de films,bandes sonores,animations,images,doublages sonores ou écrits et de tous médias quelques soient leur support et via tous les canaux de diffusions
  9. Toutes les activités se rapportant,directement ou indirectement,au domaine de la négociation,de la commercialisation et de la conclusion de contrats de produits et services pour compte de tiers
  10. Toutes les activités se rapportant,directement ou indirectement,au domaine de l’événement,notamment,et sans que cette liste soit exhaustive,le développement,la conception,l’organisation,la production,l’animation de tout événement artistique,culturel,publicitaire et promotionnel mais aussi les festivités,manifestations,séminaires,colloques stands,foires,expositions qu’ils soient du domaine privé ou du domaine public
deed of 07-02-2022 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
Avenue du Zodiaque 88 registered office 1410 Waterloo 62100 Computer programming 03-02-2022 2.327.665.250

Buildings and parcels at the address

Ground area
758 m²
Buildings
138 m²
Volume, LiDAR
784 m³
Tallest building
7.5 m
Buildings to scale, each on its own parcel
138 m², 7.5 m 138 m², 7.5 m

Location

registered office establishment The establishment unit on the map
3 companies at this address See who is registered here

Parcels

Cadastral parcelArea Buildings Height / floors
25764O0152/00B000758 m² 1 · 138 m² 7.5 m · 2